DEFINITIVE PROXY STATEMENT

Company

SANGAMO THERAPEUTICS, INC

Filed

March 11, 2014

Period of Report

April 21, 2014

Accession Number

0001193125-14-093927

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →